Collagenase Clostridium Hist.
Brand name: Santyl
Rank #217 of 500 drugs by total cost
$63.3M
Total Cost
70,641
Total Claims
$63.3M
Total Cost
2,838
Prescribers
$896
Cost per Claim
24,329
Beneficiaries
75,657
30-Day Fills
$22K
Avg Cost/Provider
25
Avg Claims/Provider
About Collagenase Clostridium Hist.
Collagenase Clostridium Hist. (sold as Santyl) was prescribed 70,641 times by 2,838 Medicare Part D providers in 2023, costing the program $63.3M. At $896 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 214 | Venlafaxine Hcl (Venlafaxine Hcl) | $64.7M | 2,187,710 |
| 215 | Canagliflozin (Invokana) | $63.7M | 66,550 |
| 216 | Belimumab (Benlysta) | $63.4M | 13,386 |
| 217 | Collagenase Clostridium Hist. (Santyl) | $63.3M | 70,641 |
| 218 | Insulin Lispro Protamin/Lispro (Humalog Mix 75-25 Kwikpen) | $62.8M | 60,873 |
| 219 | Furosemide (Furosemide) | $62.3M | 9,788,207 |
| 220 | Buprenorphine (Buprenorphine) | $61.1M | 156,598 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology